Skip to content

A Accurate Prediction Model for the Grade of Renal Fibrosis Using Magnetic Resonance Elastography and Serology

A Accurate Prediction Model for the Grade of Renal Fibrosis Using Magnetic Resonance Elastography and Serology

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000036774
Enrollment
Unknown
Registered
2020-08-25
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-09-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal fibrosis

Interventions

Index test:A&#32
Prediction&#32
Model&#32
for&#32
the&#32
of&#32
Using&#32
Magnetic&#32
Resonance&#32
and&#32
Serology&#32
(HA?LN?PC-??C-??Scr?eGFR?PRO)

Sponsors

Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Meet the diagnostic criteria of chronic kidney disease proposed by K/DOQI, renal damage or glomerular filtration rate < 60ml/min/1.73m for more than 3 months. 2. The age is between 18 and 70 years old, regardless of gender. 3. Be able to understand the whole process of the experiment, participate voluntarily and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. patients with other serious primary diseases. 2. patients with polycystic kidney, acute renal damage, renal calculi and renal artery stenosis, complicated with severe infection of urinary system and history of venereal disease with urinary tract obstruction. 3. the laboratory indexes of recent examination included abnormal liver function, severe anemia, severe dyslipidemia and so on. 4. complicated with serious complications of cardiovascular, liver, kidney and hematopoietic system, unwilling collaborators and psychotic patients. 5. take other anti-fibrosis drugs or blood-activating drugs 6 months before selection. 6. long-term heavy drinking, pregnant and lactating women and those who may be allergic to this drug. 7. patients with a history of various tumor diseases such as liver cancer, renal cell carcinoma, etc. 8. have received antiviral treatment in the past or used immunomodulators within half a year. 9. there are contraindications in magnetic resonance examination.

Design outcomes

Primary

MeasureTime frame
Renal biopsy;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactYang Xuejun

Shuguang Hospital affiliated to Shanghai University of traditional Chinese Medicine

13003226766@163.com+86 13003226766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026